Blood Glucose Monitoring Devices Market Analysis

  • Report ID: 4606
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Segmentation:

Product Segment Analysis

The global blood glucose monitoring devices market is segmented and analyzed for demand and supply by product into self-monitoring devices, and continuous glucose monitoring devices. Out of these two types of segments, the self-monitoring devices segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the ease of use provided by these devices as people can monitor their blood sugar levels through these devices in the comfort of their homes.  Further, the development of novel lancet devices with faster outcomes and less pain for the user is also anticipated to fuel market expansion. For instance, in November 2021, Intuity Medical, Inc., launched the POGO Automatic Monitor, an innovative automatic glucose monitoring device. It utilizes ten-test cartridges that include test strips and lancets instead of depending on separate test strips and lancets. At the touch of a button, the POGO Automatic instantly lances, gathers blood, and provides results in a few seconds.

Disease Type Segment Analysis

The global blood glucose monitoring devices market is also segmented and analyzed for demand and supply by disease type into type 1 diabetes, type 2 diabetes, and gestational diabetes. Amongst these three segments, the type 2 diabetes segment is expected to garner a significant share, backed by the rapidly surging prevalence of type 2 diabetes patients throughout the world. As per the World Health Organization report, type 2 diabetes accounts for more than 95% of all diabetes cases worldwide. This, as an outcome, is projected to generate numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

                     By Product

  • Self-Monitoring Devices

  • Continuous Glucose Monitoring Devices

                      By Modality

  • Wearable

  • Non-Wearable

                      By Disease Type

  • Type 1 Diabetes

  • Type 2 Diabetes

  • Gestational Diabetes

                     By Distribution Channel

  • Hospitals

  • Retail Sales

  • Homecare

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.

The global blood glucose monitoring devices market size was valued at around USD 19.71 billion in 2025 and is projected to grow at a CAGR of more than 8.2%, reaching USD 43.35 billion revenue by 2035.

North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.

Key players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos